Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Merck
AstraZeneca
Express Scripts
Colorcon

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Hydroxypropyl cellulose - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for hydroxypropyl cellulose and what is the scope of patent protection?

Hydroxypropyl cellulose is the generic ingredient in one branded drug marketed by Valeant Pharms Intl and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are forty-one drug master file entries for hydroxypropyl cellulose. One supplier is listed for this compound.

Summary for hydroxypropyl cellulose
Recent Clinical Trials for hydroxypropyl cellulose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institutes of Health (NIH)Phase 1
CONRADPhase 1
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1

See all hydroxypropyl cellulose clinical trials

Pharmacology for hydroxypropyl cellulose
Drug ClassDemulcent
Mechanism of ActionDemulcent Activity

US Patents and Regulatory Information for hydroxypropyl cellulose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms Intl LACRISERT hydroxypropyl cellulose INSERT;OPHTHALMIC 018771-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Johnson and Johnson
Baxter
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.